A prospective Cohort, Proof of concept study assessing flare-up effect of long-acting GnRH agonist Triptorelin on the first day of the menstrual cycle to increase the thickness of resisting thin endometrium and improve pregnancy outcome.
Phase of Trial: Phase IV
Latest Information Update: 27 Dec 2015
At a glance
- Drugs Triptorelin (Primary) ; Estrogen
- Indications Female infertility
- Focus Proof of concept; Therapeutic Use
- 27 Dec 2015 New trial record